Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation.
about
Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trialsBile acid receptors and nonalcoholic fatty liver diseaseObesity and insulin resistance: an abridged molecular correlationDistinct Roles for Intracellular and Extracellular Lipids in Hepatitis C Virus Infection.The effect of exposure to a high-fat diet on microRNA expression in the liver of blunt snout bream (Megalobrama amblycephala)Lipid modulatory activities of Cichorium glandulosum Boiss et Huet are mediated by multiple components within hepatocytes.pNaKtide Attenuates Steatohepatitis and Atherosclerosis by Blocking Na/K-ATPase/ROS Amplification in C57Bl6 and ApoE Knockout Mice Fed a Western Diet.E2F1 inhibits circulating cholesterol clearance by regulating Pcsk9 expression in the liver.Sasa borealis stem extract attenuates hepatic steatosis in high-fat diet-induced obese rats.Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.Extracts from Salvia-Nelumbinis naturalis alleviate hepatosteatosis via improving hepatic insulin sensitivity.Fructus Xanthii attenuates hepatic steatosis in rats fed on high-fat diet.Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methodsThe clinical significance of serum ferritin in pediatric non-alcoholic Fatty liver diseaseMicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis.Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.Replacement of Dietary Saturated Fat by PUFA-Rich Pumpkin Seed Oil Attenuates Non-Alcoholic Fatty Liver Disease and Atherosclerosis Development, with Additional Health Effects of Virgin over Refined OilLipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease.Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db miceXanthine-based KMUP-1 improves HDL via PPARγ/SR-B1, LDL via LDLRs, and HSL via PKA/PKG for hepatic fat loss.Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease.Molecular Interactions between NAFLD and Xenobiotic Metabolism.Combined treatment with caffeic and ferulic acid from Baccharis uncinella C. DC. (Asteraceae) protects against metabolic syndrome in mice.TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice.De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucoseHedgehog signaling is a potent regulator of liver lipid metabolism and reveals a GLI-code associated with steatosis.Distinctly altered gut microbiota in the progression of liver diseaseTomato Juice Consumption Modifies the Urinary Peptide Profile in Sprague-Dawley Rats with Induced Hepatic Steatosis.Effect of combined mulberry leaf and fruit extract on liver and skin cholesterol transporters in high fat diet-induced obese miceMetabolic profiling of fatty liver in young and middle-aged adults: Cross-sectional and prospective analyses of the Young Finns Study.BL153 partially prevents high-fat diet induced liver damage probably via inhibition of lipid accumulation, inflammation, and oxidative stress.Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.Normal weight dyslipidemia: Is it all about the liver?1H NMR-based serum metabolomics reveals erythromycin-induced liver toxicity in albino Wistar rats.Dyslipidemia: Obese or Not Obese-That Is Not the Question.Obesity, adipokines, and C-peptide are associated with distinct plasma phospholipid profiles in adult males, an untargeted lipidomic approach.Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study.Feeding-fasting dependent recruitment of membrane microdomain proteins to lipid droplets purified from the liver.Comparison between the efficacies of curcumin and puerarin in C57BL/6 mice with steatohepatitis induced by a methionine- and choline-deficient diet.Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes.
P2860
Q26748608-178DAB04-0531-47C2-A7B5-AA8194BEC7E0Q26775814-5DAC8D8A-59CF-4BEA-9B0B-BD28CAAA019AQ26825473-564C730F-38F6-4078-8B1B-4CAA3E7E3F44Q30276614-EE0BC8E0-B3C2-4E12-8E5C-341ED8B62219Q30391726-B1A90572-2146-4DD4-8359-32CE517540D0Q33569937-486E9218-16AE-4606-8FF0-B708A50CCB58Q33671222-904DFBF4-82D1-4871-8129-AFF84A4519ECQ33703222-6161F4B6-378E-4A76-B416-AFE9792391ECQ33813669-D8999E53-5241-4C5F-9976-BB3E1082DC5EQ34565315-FA6148A4-5BB9-4EE8-9B53-D4D9FBB851D0Q34571695-C6975543-9F0D-47EF-80F1-BBFD36FA1879Q34668012-1AC04C69-9874-490E-9D8D-3A148534ED16Q34746071-2ADCC2DB-AFA2-4A7D-BBF8-02AF2A4FE17BQ34923599-EE28A576-C9BA-4CC8-9CFC-1095815C2310Q35652509-7CB6E75C-516F-4C10-B705-5C93442D7C81Q35670773-34476A24-F8FD-42BF-885B-770557C55C6DQ35787531-CE62463A-4A7B-4D96-9FC2-C4CFF71D4EB7Q35850407-5173C19C-79F0-44F6-AFB3-F0A3F10413C9Q35935053-68E73997-AD03-44E8-961F-C1BF842659F5Q36197808-282456FC-B89D-469F-A758-B62AA5E4EA5BQ36237764-FEAC8BF9-1A99-4551-9714-7E37181B4350Q36549795-D5E15263-85EE-421A-8AFF-6E42ABF1D9D1Q36607733-82815F44-804F-4E8C-87A0-9E28363A7FA5Q36633583-99C48251-4A13-4029-838A-2776AEADBF82Q36800168-3BC3228C-49EB-4396-8F0F-55E14F5C0A6CQ36908863-344131D6-43B3-49EC-A9F1-C27CE477AA8BQ37190070-96412DFF-95D4-4474-B3F5-88B98657D50CQ37465366-548BAF3A-121A-470D-BA3E-2742FDC8E29CQ37620469-0BDE0B6B-7C14-40AA-B3B0-2E39A64959B1Q37633361-0CFABAC7-D50D-4052-B3A3-1B3B7B4B4EF1Q37719108-B066C9DD-E23E-4081-BDBC-EFD22155DEEEQ38430909-F0F34472-857A-4364-97BA-8FD13D03B288Q38730392-05C5687E-C405-4094-BDB7-B989FC97805EQ38755446-FA6E6DD2-F58E-4885-A5F0-3F905F52B147Q38968519-4F0BB59D-CD7B-47DC-98D6-71EC7292C312Q40109903-63189195-36E5-4913-9A7C-278602E47CB8Q40724787-AFFB7DF5-87C7-403C-BFDB-DF2D5D650106Q41363068-6F2D9656-C359-41BB-A1BF-CEC96BCCC422Q41942220-14036995-FCFD-4240-AE53-5AF8A3A6B566Q42284206-8BB593A2-7716-45B4-A709-469501D5B872
P2860
Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation.
@en
Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation.
@nl
type
label
Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation.
@en
Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation.
@nl
prefLabel
Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation.
@en
Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation.
@nl
P2860
P356
P1433
P1476
Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation.
@en
P2093
Klementina Fon Tacer
P2860
P304
P356
10.1155/2011/783976
P577
2011-07-02T00:00:00Z